Bioconjugation of Luminescent Silicon Quantum Dots for Selective Uptake by Cancer Cells
- 18 May 2011
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 22 (6) , 1081-1088
Abstract
Conventional quantum dots have great potential in cancer-related imaging and diagnostic applications; however, these applications are limited by concerns about the inherent toxicity of their core materials (e.g., cadmium, lead). Virtually all imaging applications require conjugation of the imaging agent to a biologically active molecule to achieve selective uptake or binding. Here, we report a study of biocompatible silicon quantum dots covalently attached to biomolecules including lysine, folate, antimesothelin, and transferrin. The particles possess desirable physical properties, surface chemistry, and optical properties. Folate- and antimesothelin-conjugated silicon quantum dots show selective uptake into Panc-1 cells. This study contributes to the preclinical evaluation of silicon quantum dots and further demonstrates their potential as an imaging agent for cancer applications.Keywords
This publication has 37 references indexed in Scilit:
- Cadmium-Free CuInS2/ZnS Quantum Dots for Sentinel Lymph Node Imaging with Reduced ToxicityACS Nano, 2010
- Paramagnetic, Silicon Quantum Dots for Magnetic Resonance and Two-Photon Imaging of MacrophagesJournal of the American Chemical Society, 2010
- Long-term Persistence and Spectral Blue Shifting of Quantum Dots in VivoNano Letters, 2009
- Biodegradable luminescent porous silicon nanoparticles for in vivo applicationsNature Materials, 2009
- Biocompatible Luminescent Silicon Quantum Dots for Imaging of Cancer CellsACS Nano, 2008
- Renal clearance of quantum dotsNature Biotechnology, 2007
- Water‐Soluble Photoluminescent Silicon Quantum DotsAngewandte Chemie International Edition, 2005
- Physicochemical Properties and Cellular Toxicity of Nanocrystal Quantum Dots Depend on Their Surface ModificationNano Letters, 2004
- Transferrin receptor is a marker of malignant phenotype in human pancreatic cancer and in neuroendocrine carcinoma of the pancreasEuropean Journal of Cancer, 2004
- Near-infrared fluorescent type II quantum dots for sentinel lymph node mappingNature Biotechnology, 2003